Adaptive Biotechnologies to Report Third Quarter Financial Results on November 10, 2020

NEXT STORY
10x Genomics to Report Third Quarter Financial Results on November 10, 2020
PREV STORY
Vir and Alnylam to Webcast Virtual Fireside Chat at H.C. Wainwright Hepatitis B Virus Mini-Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Radius Health Presents Analysis from Phase 3 ACTIVE Trial and Data from Preclinical Studies for TYMLOS® (abaloparatide) Injection at ENDO 2019 Annual Meeting

author_avatar
NASDAQ Market News

Teleflex Announces Third Quarter 2020 Earnings Conference Call Information

author_avatar
NASDAQ Market News

Axsome Therapeutics Receives FDA Agreement under Special Protocol Assessment (SPA) for the MOMENTUM Phase 3 Trial of AXS-07 in Migraine

FDA agreement achieved on Phase 3 trial design, endpoints, and statistical approach Trial to ...

author_avatar
NASDAQ Market News